Literature DB >> 17945363

Regulation of cyclooxygenase-2 expression by cyclic AMP.

Thomas Klein1, Pierre Shephard, Hartmut Kleinert, Martin Kömhoff.   

Abstract

Prostaglandins (PG) regulate many biological processes, among others inflammatory reactions. Cyclooxygenases-1 and -2 (COX-1 and COX-2) catalyse PG synthesis. Since this step is rate limiting, the regulation of COX expression is of critical importance to PG biology. Contrary to COX-1, which is constitutively expressed, COX-2 expression is subject to regulation. For example, COX-2 levels are increased in inflammatory reactions. Many signalling pathways can regulate COX-2 expression, not least those involving receptors for COX products themselves. Analysis of the intracellular signal transducers involved reveals a crucial role for cAMP, albeit as a modulator rather than direct inducer. Indeed, the influence of cAMP on COX-2 expression is complex and dependent on the cell type and cellular environment. This review aims to summarise various topics related to cAMP-dependent COX-2 expression. Firstly, the main aspects of COX-2 regulation are briefly considered. Secondly, the molecular basis for COX-2 gene (post)-transcriptional regulation is reviewed. Lastly, a detailed overview of the effects of cAMP-dependent signalling on COX-2 mRNA and protein expression in various human and rodent cells is provided. There is a large number of marketed, clinical and preclinical concepts promoting the elevation of intracellular cAMP levels for therapeutic purposes (e.g., beta(2)-agonists, PG receptor agonists, phosphodiesterase inhibitors). In this respect, the role of cAMP in the regulation of COX-2 expression, especially the human enzyme, is of significant clinical importance.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17945363     DOI: 10.1016/j.bbamcr.2007.09.001

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  26 in total

1.  Cyclooxygenase-2 deficiency leads to intestinal barrier dysfunction and increased mortality during polymicrobial sepsis.

Authors:  Laura E Fredenburgh; Margarita M Suárez Velandia; Jun Ma; Torsten Olszak; Manuela Cernadas; Joshua A Englert; Su Wol Chung; Xiaoli Liu; Cynthia Begay; Robert F Padera; Richard S Blumberg; Stephen R Walsh; Rebecca M Baron; Mark A Perrella
Journal:  J Immunol       Date:  2011-10-03       Impact factor: 5.422

2.  Major role of adipocyte prostaglandin E2 in lipolysis-induced macrophage recruitment.

Authors:  Xiaoqian Hu; Vincenza Cifarelli; Shishuo Sun; Ondrej Kuda; Nada A Abumrad; Xiong Su
Journal:  J Lipid Res       Date:  2016-02-24       Impact factor: 5.922

3.  Renal cyclooxygenase products are higher and lipoxygenase products are lower in early disease in the pcy mouse model of adolescent nephronophthisis.

Authors:  Tamio Yamaguchi; Clara Lysecki; Ashleigh Reid; Shizuko Nagao; Harold M Aukema
Journal:  Lipids       Date:  2013-11-01       Impact factor: 1.880

4.  ERK5 signalling pathway is essential for fluid shear stress-induced COX-2 gene expression in MC3T3-E1 osteoblast.

Authors:  Jin Jiang; Liang-gong Zhao; Yuan-jun Teng; Shao-long Chen; Li-ping An; Jing-ling Ma; Jing Wang; Ya-yi Xia
Journal:  Mol Cell Biochem       Date:  2015-05-15       Impact factor: 3.396

5.  Cyclooxygenase 2 inhibition slows disease progression and improves the altered renal lipid mediator profile in the Pkd2WS25/- mouse model of autosomal dominant polycystic kidney disease.

Authors:  Md Monirujjaman; Harold M Aukema
Journal:  J Nephrol       Date:  2019-01-22       Impact factor: 3.902

6.  Systemic oxygenation weakens the hypoxia and hypoxia inducible factor 1α-dependent and extracellular adenosine-mediated tumor protection.

Authors:  Stephen M Hatfield; Jorgen Kjaergaard; Dmitriy Lukashev; Bryan Belikoff; Taylor H Schreiber; Shalini Sethumadhavan; Robert Abbott; Phaethon Philbrook; Molly Thayer; Dai Shujia; Scott Rodig; Jeffrey L Kutok; Jin Ren; Akio Ohta; Eckhard R Podack; Barry Karger; Edwin K Jackson; Michail Sitkovsky
Journal:  J Mol Med (Berl)       Date:  2014-08-15       Impact factor: 4.599

7.  Roflumilast inhibits the release of chemokines and TNF-α from human lung macrophages stimulated with lipopolysaccharide.

Authors:  A Buenestado; S Grassin-Delyle; F Guitard; E Naline; C Faisy; D Israël-Biet; E Sage; J F Bellamy; H Tenor; P Devillier
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

8.  Inhibition of cyclooxygenase-2 prevents adverse effects induced by phosphodiesterase type 4 inhibitors in rats.

Authors:  D Peter; R Göggel; F Colbatzky; P Nickolaus
Journal:  Br J Pharmacol       Date:  2011-01       Impact factor: 8.739

9.  Progesterone Receptor Serves the Ovary as a Trigger of Ovulation and a Terminator of Inflammation.

Authors:  Chan Jin Park; Po-Ching Lin; Sherry Zhou; Radwa Barakat; Shah Tauseef Bashir; Jeong Moon Choi; Joseph A Cacioppo; Oliver R Oakley; Diane M Duffy; John P Lydon; CheMyong J Ko
Journal:  Cell Rep       Date:  2020-04-14       Impact factor: 9.423

10.  Prostaglandins from Cytosolic Phospholipase A2α/Cyclooxygenase-1 Pathway and Mitogen-activated Protein Kinases Regulate Gene Expression in Candida albicans-infected Macrophages.

Authors:  Bogeon Yun; HeeJung Lee; Sabarirajan Jayaraja; Saritha Suram; Robert C Murphy; Christina C Leslie
Journal:  J Biol Chem       Date:  2016-02-03       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.